|
?:authorAffiliation
|
-
[\'Computational Oncology Group, Department of Surgery and Cancer, Imperial College London, London, UK; Department of Radiotherapy, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK. Electronic address: matthew.williams@imperial.ac.uk.\', \'Computational Oncology Group, Department of Surgery and Cancer, Imperial College London, London, UK; Department of Radiotherapy, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.\', \'Computational Oncology Group, Department of Surgery and Cancer, Imperial College London, London, UK; Clinical Experimental Center, Jiangmen Key Laboratory of Clinical Biobanks and Translational Research, Jiangmen Central Hospital, Affiliated Jiangmen Hospital of Sun Yat-sen University, Jiangmen, China; Department of Oncology, Jiangmen Central Hospital, Affiliated Jiangmen Hospital of Sun Yat-sen University, Jiangmen, China.\', \'Computational Oncology Group, Department of Surgery and Cancer, Imperial College London, London, UK; Brain Tumour Research Centre, Imperial College London, London, UK.\', \'Department of Oncology, Addenbrooke\'s Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}